Douglas Faller
Equibles does not estimate personal net worth.
Get an email with a short summary when Imunon, Inc. publishes a filing, an earnings call transcript or a press release.
Get IMNN alertsAbout Douglas Faller
Imunon, Inc. reported in an 8-K filed February 10, 2025 that Douglas Faller was appointed Chief Medical Officer, effective February 18, 2025. The proxy statement of Imunon, Inc. reports total compensation of $589,810 for Douglas Faller in fiscal 2025, including a base salary of $387,692. Imunon, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Imunon, Inc. includes Corinne Le Goff (CEO and Board Member), Michael Tardugno (CEO and Chairman), Stacy Lindborg (CEO and Board Member) and 7 others.
“On February 9, 2025, the Board of Directors of Imunon, Inc. (the "Company") appointed Dr. Douglas Faller (age 72) as Chief Medical Officer.”
Affiliation history
-
Imunon, Inc. (IMNN)
Proxy statement
CurrentStart not stated–present
Last confirmed May 4, 2026
Company network
Leadership on record at Imunon, Inc.
- Corinne Le Goff CEO, Board Member
- Michael Tardugno CEO, Chairman
- Stacy Lindborg CEO, Board Member
- Stacy R. Lindborg CEO, Board Member
- Stacy R. Lindborg, Ph.D. CEO
- Michael H. Tardugno Chairman
- David Gaiero CFO
- Josh Blacher CFO
- Kimberly Graper CFO
- Susan Eylward General Counsel
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Imunon, Inc. (IMNN) | Chief Medical Officer | $387,692 | $589,810 |